Haplotype identity between individuals who share a CFTR mutation allele 'identical by descent': Demonstration of the usefulness of the haplotype-sharing concept for gene mapping in real populations by Vries, H.G. (Hendrik) de et al.
Abstract Cystic fibrosis (CF) patients with the A455E
mutation, in both the French Canadian and the Dutch pop-
ulation, share a common haplotype over distances of up to
25 cM. French Canadian patients with the 621+1G→T
mutation share a common haplotype of more than 14 cM.
In contrast, haplotypes containing the ∆F508 mutation
show haplotype identity over a much shorter genomic dis-
tance within and between populations, probably because
of the multiple introduction of this most common muta-
tion. Haplotype analysis for specific mutations in CF or in
other recessive diseases can be used as a model for study-
ing the occurrence of genetic drift conditional on gene fre-
quencies. Moreover, from our results, it can be inferred
that analysis of shared haplotypes is a suitable method for
genetic mapping in general.
Introduction
In recent times, it has been repeatedly observed that hap-
lotypes surrounding rare alleles of a gene are large (Rozen
et al. 1990; Cannon-Albright et al. 1994; Gruis et al. 1994;
Nystrom-Lahti et al. 1994; Houwen et al. 1994; Hast-
backa et al. 1994; Sulisalo et al. 1994; Meyers et al. 1994;
Heyer and Tremblay 1995). Sharing of large genomic ar-
eas can be used as a method for mapping disease genes:
this is termed identity by descent (IBD) mapping (Houwen
et al. 1994; te Meerman et al. 1995). An empirical ques-
tion is whether haplotype sharing can be observed in real
populations to an extent where IBD mapping using haplo-
type sharing is feasible.
As an empirical model for high and low frequency al-
leles weakly associated with a disease or with dominance
and low penetrance, we have chosen to study mutations
leading to the recessive disease cystic fibrosis (CF). Only
a small fraction of the disease alleles present in the popu-
lation can be observed in diseased individuals. To date,
more than 500 presumed mutations have been identified
in the CF transmembrane conductance regulator gene. The
most common mutation (∆F508) has a high frequency in
Caucasian populations (up to 1.5%). A less frequent mu-
tation is the A455E missense mutation. According to data
from the CF consortium (Cystic Fibrosis Genetic Analysis
Consortium 1994), this mutation is mainly detected among
French Canadian and Dutch CF patients. The A455E mu-
tation comprises 8% of all CF mutations in the French
Canadian population of the Saguenay-Lac St. Jean region
of Quebec (Rozen et al. 1992) and 3% in The Netherlands
(unpublished data). The overall CF carrier frequency is 1
in 15 in this particular French Canadian population (Ro-
zen et al. 1992) and 1 in 30 in The Netherlands (ten Kate
1977). This results in allele frequencies of 1/400 (8% of
1/30) and 1/2000 (3% of 1/60), respectively. The concen-
trated geographical distribution indicates that this muta-
tion has been recently introduced.
In models for multifactorial disease, the mutated gene
concept is not directly applicable, since alleles act as risk
factors in combination with other factors. However, if gene/
gene or gene/environment interactions are modelled in
founder populations, where the multifactorial background
is more in common than in mixed populations, specific al-
leles of genes may be involved, leading to association at
the population level. The implication is that such alleles
show increased frequencies in affected individuals. It can-
not be ruled out that multifactorial diseases are deter-
mined by only a few genes; this would make an increased
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frequency of specific alleles in affected individuals even
more likely (van Ommen 1995). By studying haplotype
sharing in two populations, one with a very late origin
(French Canadians) and one with a longer history (south-
ern part of The Netherlands), we demonstrate the useful-
ness of the haplotype-sharing concept for gene mapping
in real populations.
Materials and methods
Recruitment of CF patients
The A455E mutation, which is associated with a less severe CF
phenotype, has mainly been detected in Canada and in The Nether-
lands (Cystic Fibrosis Genetic Analysis Consortium 1994). In
Canada, this mutation was introduced by French immigrants dur-
ing the period 1650–1900 (Rozen et al. 1990, 1992). The Dutch
patients with an A455E mutation all come from southern parts of
The Netherlands (unpublished results). Blood samples from 15 in-
dependent Dutch CF patients with the A455E mutation were col-
lected in Groningen and Rotterdam. Samples from 10 French
Canadian CF patients with the A455E mutation, from a subpopu-
lation in north-eastern Quebec, viz., the Saguenay-Lac St.Jean re-
gion (Rozen et al. 1990, 1992), were collected in Montreal. The fa-
ther of proband 3 and the mother of proband 6 were carriers of the
621+1G→T mutation and were sibs. Because all patients were
compound heterozygotes, haplotype sharing could also be deter-
mined around two other CF mutations (∆F508, 621+1G→T). Clin-
ical diagnosis in all patients was confirmed by demonstrating the
∆F508 (Scheffer et al. 1989), A455E (Kerem et al. 1990), and
621+1G→T (Zielenski et al. 1991a) mutations. In all cases, DNA
from one of the parents was used for phase determination.
Microsatellite analysis
Three intragenic microsatellites, IVS8CA (intron 8), IVS17BTA,
and IVS17BCA (intron 17b; Zielenski et al. 1991b) and 7 extra-
genic microsatellites, D7S518, D7S501, D7S523, D7S486, D7S480,
D7S490, and D7S635 (Gyupay et al. 1994), were analyzed by sin-
gle amplification. The primer sequences are shown in Table 1. The
polymerase reaction (PCR) was performed with 400 ng DNA, 50
mM KCl, 10 mM TRIS (pH 9.0), 1.5 mM MgCl2, 0.01% gelatin,
0.1% Triton X-100, 0.5 µM of each microsatellite primer (biotiny-
lated), and 0.25 U Super Taq (SphearoQ), in a total volume of 50
µl. Part of the PCR product was diluted to 1:20 and mixed with a
formamide solution. Absolute PCR product sizes were determined
by adding standard size markers (generated from Pharmacia
m13mp18) to each sample. The reaction products were detected in
a 6% denaturing polyacrylamide gel with an Automated Laser Flu-
orescent system (Pharmacia LKB). In total, a region of 25 cM
flanking the CF gene was genotyped. For certain microsatellite al-
leles, it was not possible to establish phase. In these cases, haplo-
types were assigned by comparing alleles of flanking microsatel-
lites between the CF patients.
Results
The results of the haplotype analysis of the Canadian and
Dutch CF patients with a A455E mutation are shown in
Table 2. The haplotype of the intragenic markers on the
A455E chromosome of the 10 French Canadian patients is
identical in all cases, namely 22–35–13, in which the
numbers represent the numbers of repeats of IVS8CA,
IVS17BTA, and IVS17BCA, respectively. The extragenic
alleles are numbered according to the relative length of
the PCR product. Of the 10 Canadian patients, 9 share a
region of at least 5 cM surrounding the A455E mutation
(Fig. 1). Patient nos. 1, 2, and 3 share a region of more
than 25 cM. This is also the case, with a different haplo-
type, for patient nos. 4, 5, and 6. The haplotype of the in-
tragenic markers of 14 of the 15 Dutch patients are identi-
cal to the Canadian patients. They share a region of more
than 4 cM surrounding A455E (Fig. 2). The remaining pa-
tient shows a different intragenic haplotype (22–37–13).
The haplotypes of the non-A455E chromosomes of the
Canadian and Dutch patients are shown in Table 3. Four
Canadian patients have a 621+1G→T mutation on the
other CF chromosome, and six have a ∆F508 mutation.
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Table 1 PCR primers of mi-
crosatellites at and flanking the
CF locus. Data have been de-
rived from Zielenski et al.
(1991b) and Gyapay et al.
(1994)
Marker Primer sequences 5′→3′ Hetero- Distance to
zygosity CFTR gene (cM)
D7S518 CAGTAGGCAGGGGTGG 0.87 15
GGGTGTGTCTGTGTGACAAC
D7S501 CACCGTTGTGATGGCAGAG 0.81 7
ATTTCTTACCAGGCAGACTGCT
D7S523 CTGATTCATAGCAGCACTTG 0.80 1
AAAACATTTCCATTACCACTG
D7S486 AAAGGCCAATGGTATATCCC 0.81 0.2
GCCAGGTGATTGATAGTGC
IVS8BTA TCTATCTCATGTTAATGCTG 0.41 0
GTTTCTAGAGGACATGATC
IVS17BTA GACAATCTGTGTGCATCG 0.89 0
GCTCGATTCTATAGGTTATC
IVS17BCA AAACTTACCGACAAGAGGA 0.38 0
TGTCACCTCTTCATACTCAT
D7S480 CTTGGGGACTGAACCATCTT 0.86 2
AGCTACCATAGGGCTGGAGG
D7S490 CCTTGGGCCAATAAGGTAAG 0.78 5
AGCTACTTGCAGTGTAACAGCATTT
D7S635 CCAGGCCATGTGGAAC 0.81 10
AGTTCTTGGCTTGCGTCAGT
Out of the 15 Dutch CF patients, 13 have a ∆F508 muta-
tion on the other chromosome. The two remaining Dutch
patients, nos. 2 and 10, have the 1717–1G→A and the
R553X mutation, respectively, on their other chromo-
some. The French Canadian patients with the 621+1G→T
mutation have identical intragenic haplotypes (21–31–13)
and share a DNA region of more than 14 cM. Little or no
sharing can be observed when the ∆F508 chromosomes in
and between the two populations are compared.
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Table 2 Microsatellite haplo-
types for independent A455E
chromosomes from a French
Canadian and a Dutch popula-
tion (! phase unknown)
5 3 2 Intragenic 1 6 8 (cM)
ˆ ˆ ˆ ˆ ˆ ˆ
D7S-635 490 480 8CA 17BTA 17BCA 486 523 501 518
French Canadian patients
1 7 ! 1 3 22 ! 35 ! 13 8 4 5 10
2 7 1 3 22 35! 13 8 4 ! 5 10
3 7 1 3 22 35 13 8 4 5 ! 10
4 3 ! 4 3 22 ! 35 13 8 4 5 10
5 3 4 3 22 35 13 8 4 5 10
6 3 4 3! 22 35 13 8 4 5 ! 10
7 1 ! 1 2 22 ! 35 13 8 4 5 2
8 1 1 2 22 35 13 8 4 ! 4 10
9 4 ! 2 2 22 35 13 8 4 5 10
10 7 1 ! 3 22 35 13 8 3 3 2
Dutch patients
1 7 1 3 22 35! 13 8 4 3 2
2 1 1 3 22 ! 35 13 8 4 1 12
3 1 4 6 22 35 13 8 4 1 ! 4 !
4 6 1 3 22 35 13 8 5 7 9
5 6 1 3 22 35 13 8 5 7 9
6 6 1 3 22 ! 35 13 8 5 5 2
7 6 1 ! 3 22 35 13 10 5 5 2
8 1 1 3! 22 35 13 8 5 ! 3 11
9 4 1 3 22 37 13 8 5 3 10
10 3 1 3 22 ! 35 13 8 3 3 12 !
11 5 6 3 22 35 13 8 5 6 2
12 8 2 3 22 ! 35 13 8 5 7 2
13 5 ! 6 3 22 35 13 8 3 7 ! 10
14 10 2 3 22 35 13 8 ! 2 3 3
15 1 4 5 22 35! 13 8 5 7 3
Fig.1 DNA sharing around
the CF gene of 10 unrelated
French Canadian CF patients
(C1–10) with the A455E muta-
tion. DNA regions with the
same grade of shading repre-
sent identical haplotypes.
White regions represent unique
haplotypes within this popula-
tion
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Table 3 Microsatellite haplo-
types for independent ∆F508
and 621+1G→T chromosomes
from a French Canadian and a
Dutch population (! phase un-
known)
5 3 2 Intragenic 1 6 8 (cM)
ˆ ˆ ˆ ˆ ˆ ˆ
D7S-635 490 480 8CA 17BTA 17BCA 486 523 501 518
French Canadian patients
2 621+1G→T 1 4 5 21 31! 13 8 5 ! 7 3
3 621+1G→T 1 4 5 21 31 13 8 5 1 ! 6
6 621+1G→T 1 4 5 ! 21 31 13 8 5 7 ! 5
9 621+1G→T 1! 4 5 21 31 13 8 5 5 2
1 ∆F508 9! 3 1 17 ! 32 ! 13 8 7 1 3
7 ∆F508 9! 3 1 17 ! 32 13 8 1 5 2
4 ∆F508 7! 4 1 17 ! 32 13 8 7 1 4
5 ∆F508 9 6 7 17 ! 32 13 5 5 7 5
8 ∆F508 2 4 3 17 35 17 3 5 ! 8 7
10 ∆F508 8 4! 2 23 31 13 11 5 3 4
Dutch patients
5 ∆F508 6 1 6 17 31 13 10 4 3 2
7 ∆F508 1 6! 8 17 31 13 10 6 5 9
8 ∆F508 4 2 7! 17 31 13 10 3 ! 6 11
15 ∆F508 1 6 5 17 31! 13 10 2 7 4
1 ∆F508 4 1 3 17 31! 13 3 3 4 2
9 ∆F508 8 6 3 17 31 13 8 4 1 7
6 ∆F508 7 3 3 17 ! 32 13 8 2 1 2
11 ∆F508 1 4 7 17 32 13 8 6 5 9
14 ∆F508 1 2 1 17 32 13 5 ! 3 7 7
4 ∆F508 3 3 2 17 35 17 10 5 4 2
12 ∆F508 8 1 2 17 ! 35 17 10 2 7 4
13 ∆F508 4! 1 5 17 47 13 10 4 8 ! 3
3 ∆F508 1 2 1 23 31 13 8 5 5 ! 10 !
10 1717 1G–A 1 1 3 17! 35 16! 8 3 7 6 !
2 R553X 1 1 6 11 55 17! 10 5 8 7
Fig. 2 DNA sharing around
the CF gene of 15 unrelated
Dutch CF patients (D1–15)
with the A455E mutation.
DNA regions with the same
grade of shading represent
identical haplotypes. White re-
gions represent unique haplo-
types within this population
Discussion
The Saguenay-Lac St.Jean region was settled by approxi-
mately 5000 immigrant families during 1838–1911 (Ro-
zen et al. 1990). The identical haplotype of the intragenic
markers and the sharing of large DNA regions on the
A455E chromosomes indicate that the A455E mutations
that we now observe result from a single introduction into
this population. The three intragenic markers in the Dutch
population show the same haplotype. Furthermore, some
of the Canadian and Dutch patients share a region of more
than 4 cM around the CF gene. This indicates that the
A455E mutation has been inherited from a not-too-distant
predecessor. In the same French Canadian population, ex-
tensive sharing of haplotypes surrounding the mutated
myotonic dystrophia and rickettsia genes has been dem-
onstrated (Bétard et al. 1995). Dutch patient no. 9 shows
the only aberrant haplotype (22–37–13). This can best be
explained by a mutation in the original haplotype, because
the neighboring markers in this patient are comparable
with almost all the other Dutch patients.
The ∆F508 mutation is a very old mutation that was in-
troduced at least 52 000 years ago into Europe (Morral et
al. 1994). Much variation is observed in intragenic mark-
ers; this is probably because of repeat length mutations
subsequent to the ∆F508 mutation. This most frequent CF
mutation has been widely distributed, especially in Cau-
casian populations, over a long period of time. In the
Saguenay-Lac St.Jean region, we have detected 3 differ-
ent intragenic haplotypes in only 6 patients with a ∆F508
mutation. This means that there were probably multiple
independent introductions of the ∆F508 mutations into
this population. Sharing of DNA regions surrounding
∆F508 mutations is limited to individuals with the same
haplotype of intragenic markers. The observed intragenic
haplotypes are also the most common haplotypes in Eu-
rope (Morral et al. 1994). To detect haplotype sharing sur-
rounding ∆F508 mutations, more observations with iden-
tical intragenic haplotypes are necessary.
If the size of a shared haplotype is large, the common
predecessor must be recent. The difference in the extent of
sharing found for the ∆F508 mutation and for the other
mutations shows that haplotype sharing can be expected
to occur only if a limited number of independent intro-
ductions of a gene has been made into the population.
Haplotype sharing and other association studies can there-
fore be expected to be successful in founder populations
of a specific size relative to the gene frequency. Because
of genetic drift, the independent introduction of 10–20
copies will lead to perhaps 1–4 copies remaining in
widely varying numbers of individuals after 8 or more
generations. This is in agreement with the theoretical ex-
pectation according to Fisher (Vogel and Motulski 1986),
who computed that the probability of survival of a single
gene in a stable population after 10 generations is about
10%. It appears from the French Canadian genealogical
data that gene flow cannot be traced back to unique pre-
decessors, even if all genealogical data are complete. The
informativity of genealogical data therefore seems limited
relative to the information being learned from direct hap-
lotype comparison.
The similarity in intragenic ∆F508 haplotypes in the
two populations suggests a multiple introduction of the
same intragenic haplotypes, of which some have survived.
In Finland, genetic drift has led, by this process, to a low
CF frequency and to a distribution of mutations different
from that of the rest of Europe (de la Chapelle 1993).
The suitability of a population for haplotype-sharing
studies will increase if there is a larger population with
which the founder population is connected. Once a ge-
nomic region has been identified that possibly contains an
allele predisposing to a disease, it is easy to perform a
genome screening in affected individuals at the 1 cM
level. This situation seems to exist both for the French
Canadians and in The Netherlands, where more isolated
areas are connected with larger populations. At genomic
distances of 1 cM, association and linkage disequilibrium
can be detected in populations much larger than the one
originally investigated. At the same time, a large number
of meioses is being observed implicitly, thus narrowing
the region in which the gene must be located. This is well
illustrated from the consistent overlap shown in and be-
tween Figs. 1 and 2. In The Netherlands, the A455E data
come from an unselected population, which shows that,
for rare genes such as the A455E mutation, founder ef-
fects are present at the population level. A complication in
haplotype comparison is marker allele mutation. In this
dataset, we probably observe two such mutations (Dutch
patients nos. 7 and 9 show an allele mutation in the mi-
crosatellites D7S486 and IVS17BTA, respectively) where
the haplotype for surrounding markers seems to be con-
served.
The present study shows that the suitability of popula-
tions for gene mapping through direct haplotype compar-
ison can be investigated using some of the well-known re-
cessive disease mutations that can easily be detected at the
level of carriers. These mutations generally have a high
frequency, as would be expected for alleles of genes in-
volved in multifactorial diseases. By relating the gene fre-
quency to the size of the shared haplotypes, an impression
can be obtained regarding whether haplotype-sharing
analysis can be used to find the map location of other
genes.
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